lonapalene has been researched along with Psoriasis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berks, AH; Jones, GH; Kruseman, M; Loe, BE; Maloney, PJ; Murthy, DV; Simpson, RA; Spires, DA; Venuti, MC; Young, JM | 1 |
| Jones, GH; Loe, BE; Venuti, MC; Young, JM | 1 |
| Gawlik, I; Leukel, P; Müller, K; Ziereis, K | 1 |
| Fogh, K; Herlin, T; Iversen, L; Kragballe, K | 1 |
| Akers, WA; Franz, TJ; Johnson, JI; Lehman, PA; Olerud, JE; Tomlinson, RV | 1 |
| Black, AK; Camp, RD; Cunningham, FM; Greaves, MW; Hofbauer, M; Mallet, AI | 1 |
| Berry, PW; Bowen, JL; Tomlinson, RV | 1 |
| Forsstrom, S; Lassus, A | 1 |
2 trial(s) available for lonapalene and Psoriasis
| Article | Year |
|---|---|
Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipoxygenase Inhibitors; Male; Middle Aged; Naphthalenes; Psoriasis | 1990 |
A dimethoxynaphthalene derivative (RS-43179 gel) compared with 0.025% fluocinolone acetonide gel in the treatment of psoriasis.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Fluocinolone Acetonide; Humans; Male; Middle Aged; Naphthalenes; Psoriasis; Random Allocation | 1985 |
6 other study(ies) available for lonapalene and Psoriasis
| Article | Year |
|---|---|
Topical nonsteroidal antipsoriatic agents. 1. 1,2,3,4-Tetraoxygenated naphthalene derivatives.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Topical; Animals; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Biological Assay; Edema; Female; Humans; Lipoxygenase Inhibitors; Mice; Naphthalenes; Neutrophils; Ornithine Decarboxylase Inhibitors; Oxygen; Psoriasis; Structure-Activity Relationship; Tetrahydronaphthalenes | 1986 |
Topical nonsteroidal antipsoriatic agents. 2. 2,3-(Alkylidenedioxy)naphthalene analogues of lonapalene.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Edema; Mice; Naphthalenes; Psoriasis; Structure-Activity Relationship | 1988 |
Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition.
Topics: Administration, Topical; Animals; Anthracenes; Anti-Inflammatory Agents; Antioxidants; Cattle; Cell Division; Cells, Cultured; Humans; Hydroxyeicosatetraenoic Acids; Keratinocytes; Leukotriene B4; Lipid Peroxidation; Liposomes; Lipoxygenase Inhibitors; Malondialdehyde; Molecular Structure; Neutrophils; Oxidation-Reduction; Psoriasis; Structure-Activity Relationship | 1994 |
Modulation of eicosanoid formation by lesional skin of psoriasis: an ex vivo skin model.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonic Acid; Calcimycin; Chromatography, High Pressure Liquid; Dinoprostone; Eicosanoids; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Leukotriene B4; Lipoxygenase Inhibitors; Naphthalenes; Psoriasis; Radioimmunoassay; Skin | 1993 |
Percutaneous absorption and metabolism of lonapalene in psoriatic skin.
Topics: Administration, Cutaneous; Chromatography, High Pressure Liquid; Humans; In Vitro Techniques; Lipoxygenase Inhibitors; Male; Naphthalenes; Psoriasis; Skin Absorption | 1992 |
Dermal absorption of lonapalene, a new anti-psoriatic drug.
Topics: Animals; Dermatologic Agents; Dogs; Humans; Kinetics; Macaca mulatta; Naphthalenes; Psoriasis; Rats; Rats, Inbred Strains; Skin Absorption | 1987 |